Ligand Pharmaceuticals Ownership & Insider Activity

Ligand Pharmaceuticals (LGND) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 10.5% of shares outstanding. Institutional investors hold 91.5%. Over the past 90 days, insiders made 4 sales worth $5.0M.

Shares Outstanding

19.936M

Shares Float

16.626M

Insider Shares Owned

2.098M

Insider % Owned

10.5%

Institutional Shares Held

21.966M

Institutional % Held

91.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$5.0M total

Net Activity

Net Selling

Net Value (90d)

-$5.0M

Ligand Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Andrew Reardon	CLO & SECRETARY	SELL	4.660K	$178.17	$1.5M
Sep 10, 2026	Martine Zimmermann	DIRECTOR	SELL	1.200K	$285.00	$342K
Sep 3, 2026	Andrew Reardon	CLO & SECRETARY	SELL	5.000K	$286.09	$1.4M
Aug 12, 2026	Octavio Espinoza	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$174.49	$7.4M
Aug 12, 2026	Jason Haas	DIRECTOR	SELL	1.000K	$172.18	$1.8M
Aug 3, 2026	Andrew Reardon	CLO & SECRETARY	SELL-OPTIONS	—	$170.63	$1.2M
Jun 30, 2026	Andrew Reardon	CLO & SECRETARY	SELL-OPTIONS	132.000	$184.17	$1.3M
Jun 16, 2026	Stephen L Sabba	DIRECTOR	SELL-OPTIONS	—	$160.06	$403K
Jun 12, 2026	Jason Haas	DIRECTOR	SELL	2.461K	$153.57	$1.4M
Jun 10, 2026	John L LaMattina	DIRECTOR	SELL	4.591K	$250.88	$1.2M
Jun 5, 2026	Jason Aryeh	DIRECTOR	SELL	4.164K	$250.00	$1.3M
Jun 1, 2026	Andrew Reardon	CLO & SECRETARY	SELL-OPTIONS	—	$139.67	$874K
May 1, 2026	John W Kozarich	DIRECTOR	SELL	467.000	$147.33	$422K
May 1, 2026	Andrew Reardon	CLO & SECRETARY	SELL-OPTIONS	—	$141.79	$895K

Date	Member	Party	Chamber	Action	Amount
May 29, 2026	Gilbert Ray Cisneros	D	House	Purchase	$1,001 - $15,000
Mar 3, 2026	Gilbert Ray Cisneros	D	House	Purchase	$1,001 - $15,000
Jan 15, 2026	Gilbert Ray Cisneros	D	House	Purchase	$1,001 - $15,000
Jan 5, 2026	Gilbert Ray Cisneros	D	House	Purchase	$1,001 - $15,000